Annual Review | Annual Lecture | New members | Engagement | R&D Decade | Place
|
Ensuring the long-term health of science and engineering
CaSE has published its Annual Review for 2019/20, giving a summary of its activities and campaign successes over the last year.
This year, despite the effects of the Covid-19 pandemic, CaSE has made important strides in enhancing the environment for UK science and engineering and ensuring its long-term health.
These include:
|
CaSE Annual Lecture 2020 with the Chief Executive of UKRI
CaSE is delighted to announce that its Annual Lecture will be given by the new Chief Executive of the UK Research & Innovation, Professor Dame Ottoline Leyser, on Thursday 5th November.
At the lecture Professor Leyser will discuss the future direction of the relationship between science and society. We look forward to Professor Leyser's insight into how science, research and innovation can contribute to the Government's R&D agenda, and how the UK's research and innovation system could be better positioned to fuel a more inclusive society and economy.
Due to Covid-19 this year's lecture will take place online. You can register for the event here.
The event is kindly sponsored by Elsevier.
|
CaSE welcomes new organisational members
With new and existing challenges on the horizon, it is vitally important that the entire sector comes together to ensure UK science and innovation has the investment, the skills, and the collaborative connections to thrive. We look forward to working with our growing membership to achieve these shared ambitions.
If you would like to find out more about joining CaSE and the benefits of organisational membership, please get in touch.
|
A busy summer of political and sector-wide engagement
CaSE has been working hard over the last few months to engage with the entire sector and feed these discussions into our conversations with all levels of government.
CaSE staff have taken part in recent workshops with the Science Minister and Whitehall officials on future UK-EU scientific collaboration, the R&D Roadmap, and the effects of Covid-19 on the UK research base, as well as meeting with the Labour Shadow Science Minister to discuss Labour's policies towards science and engineering. CaSE also submitted evidence to Parliamentary inquiries on a range of important topics including ARPA, the R&D roadmap, the Spending Review and the impact of Covid-19.
CaSE has also provided its insight by speaking at a number of virtual policy webinars, including ones hosted by the Cancer Research UK Council, the UK Science Park Association, the Engineering Professors' Council and the All Party Group for STEM in Northern Ireland.
As well as group sessions, we've also held a number of virtual one-on-one meetings with members and other stakeholders, including AIRTO, the Association of the British Pharmaceutical Industry, the Association of Medical Research Charities, Bangor University, the British Psychological Society, Cancer Research UK, Imperial College London, MSD, the National Measurement Laboratory, University College London, University of Westminster, and the UK Mission to the EU.
|
Next steps on advocating for R&D investment
CaSE and the Wellcome Trust have embarked on the next stage of our R&D Decade joint-project, looking at how the R&D community can best sustain political and public support for increased investment over the next ten years.
This follows the publication of a report with policy specialists Public First, Advocating for R&D Investment, which sets out different advocacy models for how the research community can make a fresh and compelling case to political leaders and the public.
We're continuing our conversations with the R&D community through a series of ongoing workshops, to talk through the findings of the report and inform our next steps.
|
The 'levelling up' agenda
This follows the publication of our new report The Power of Place, on how to maximise the local economic impact of greater R&D intensity across the regions and nations of the UK. We were pleased to see the government take on board many of the report's recommendations, including the importance of identifying and investing in excellence and fully involving local and regional leaders across the UK in decisions about R&D investment.
|
|
